Clinical Trial Update: Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid Dyslexia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating atomoxetine for treating ADHD in children and adolescents with comorbid dyslexia; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Dyslexia

Drugs mentioned

• Atomoxetine (Atomoxetine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Attention Deficit Hyperactivity Disorder, Dyslexia | Phase 4 | Status: COMPLETED | Results posted: 2011-12-15